Ju Hwan Cho

1.2k total citations
27 papers, 585 citations indexed

About

Ju Hwan Cho is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Ju Hwan Cho has authored 27 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Physiology. Recurrent topics in Ju Hwan Cho's work include Protein Kinase Regulation and GTPase Signaling (5 papers), Bone health and treatments (4 papers) and Asthma and respiratory diseases (4 papers). Ju Hwan Cho is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), Bone health and treatments (4 papers) and Asthma and respiratory diseases (4 papers). Ju Hwan Cho collaborates with scholars based in South Korea, United States and France. Ju Hwan Cho's co-authors include Joong‐Soo Han, Shin‐Young Park, Fen Xia, Ki‐Sung Lee, Doo‐Yi Oh, Myung‐Ju Ahn, Sung Hoon Kim, Yong Hae Baik, Jae‐Won Oh and Jung Han Lee and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Ju Hwan Cho

27 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju Hwan Cho South Korea 15 335 154 138 94 74 27 585
Vanessa F. Merino United States 18 452 1.3× 145 0.9× 134 1.0× 126 1.3× 62 0.8× 26 878
Mélanie Lambert France 14 456 1.4× 148 1.0× 126 0.9× 123 1.3× 126 1.7× 28 802
Taekwon Son South Korea 14 364 1.1× 142 0.9× 106 0.8× 51 0.5× 66 0.9× 26 576
Anna Smith United States 14 600 1.8× 192 1.2× 191 1.4× 135 1.4× 114 1.5× 22 905
Karl Deacon United Kingdom 12 431 1.3× 127 0.8× 115 0.8× 103 1.1× 71 1.0× 13 668
Jianwen Zhang China 16 382 1.1× 140 0.9× 227 1.6× 46 0.5× 69 0.9× 27 641
Maria Teresa Rizzo United States 13 254 0.8× 128 0.8× 83 0.6× 56 0.6× 86 1.2× 40 601
Nathan Lanning United States 16 530 1.6× 178 1.2× 238 1.7× 68 0.7× 50 0.7× 19 872
Jee‐Youn Kim South Korea 13 472 1.4× 130 0.8× 236 1.7× 76 0.8× 52 0.7× 28 696
Brendan D. Looyenga United States 15 442 1.3× 130 0.8× 162 1.2× 59 0.6× 82 1.1× 25 734

Countries citing papers authored by Ju Hwan Cho

Since Specialization
Citations

This map shows the geographic impact of Ju Hwan Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Hwan Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Hwan Cho more than expected).

Fields of papers citing papers by Ju Hwan Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Hwan Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Hwan Cho. The network helps show where Ju Hwan Cho may publish in the future.

Co-authorship network of co-authors of Ju Hwan Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Ju Hwan Cho. A scholar is included among the top collaborators of Ju Hwan Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju Hwan Cho. Ju Hwan Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Kai, et al.. (2023). A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC). Cells. 12(19). 2393–2393. 2 indexed citations
2.
Cho, Ju Hwan, Jianxun Yi, Ki Ho Park, et al.. (2023). Quantification of autophagy flux in isolated mouse skeletal muscle fibers with overexpression of fluorescent protein mCherry-EGFP-LC3. STAR Protocols. 4(1). 101871–101871. 2 indexed citations
3.
Cho, Ju Hwan, Travis S. Johnson, Gregory A. Otterson, et al.. (2020). Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer. Lung Cancer. 146. 36–41. 13 indexed citations
4.
Cho, Ju Hwan, Kyubo Kim, Sun Hee Choi, et al.. (2019). Serum levels of periostin and exercise-induced bronchoconstriction in asthmatic children. World Allergy Organization Journal. 12(1). 100004–100004. 9 indexed citations
5.
Sizemore, Steven T., Manchao Zhang, Ju Hwan Cho, et al.. (2018). Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repair. Cell Research. 28(11). 1090–1102. 57 indexed citations
6.
Cho, Ju Hwan, Filiz Öezkan, Michael J. Koenig, et al.. (2017). Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer. Current Pharmacology Reports. 3(6). 360–373. 9 indexed citations
7.
Abana, Chike O., Ju Hwan Cho, Amy J. Graves, et al.. (2017). IL-6 variant is associated with metastasis in breast cancer patients. PLoS ONE. 12(7). e0181725–e0181725. 37 indexed citations
8.
Schrock, Morgan S., Bahadır Batar, Juhun Lee, et al.. (2016). Wwox–Brca1 interaction: role in DNA repair pathway choice. Oncogene. 36(16). 2215–2227. 34 indexed citations
9.
Jiang, Guochun, Isabelle Plo, Tong Wang, et al.. (2013). BRCA1-Ku80 Protein Interaction Enhances End-joining Fidelity of Chromosomal Double-strand Breaks in the G1 Phase of the Cell Cycle. Journal of Biological Chemistry. 288(13). 8966–8976. 43 indexed citations
10.
Han, Joong‐Soo, Shin‐Young Park, Ju Hwan Cho, et al.. (2012). A Single Nucleotide Polymorphism in the Phospholipase D1 Gene is Associated with Risk of Non-Small Cell Lung Cancer. International Journal of Biomedical Science. 8(2). 122–127. 10 indexed citations
11.
Baek, Hey‐Sung, et al.. (2012). Ratio of Leukotriene E4to Exhaled Nitric Oxide and the Therapeutic Response in Children With Exercise-Induced Bronchoconstriction. Allergy Asthma and Immunology Research. 5(1). 26–26. 10 indexed citations
14.
Park, Shin‐Young, Ju Hwan Cho, Doo‐Yi Oh, et al.. (2009). House Dust Mite Allergen Der f 2-induced Phospholipase D1 Activation Is Critical for the Production of Interleukin-13 through Activating Transcription Factor-2 Activation in Human Bronchial Epithelial Cells. Journal of Biological Chemistry. 284(30). 20099–20110. 25 indexed citations
15.
Park, Shin‐Young, et al.. (2009). Phospholipase D2 acts as an important regulator in LPS-induced nitric oxide synthesis in Raw 264.7 cells. Cellular Signalling. 22(4). 619–628. 13 indexed citations
16.
Cho, Ju Hwan, Eun‐Young Kim, Shin‐Young Park, et al.. (2008). Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783(5). 912–923. 29 indexed citations
17.
Park, Shin‐Young, Yong Hae Baik, Ju Hwan Cho, et al.. (2008). Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells. Cytokine. 44(1). 126–134. 37 indexed citations
18.
Oh, Doo‐Yi, Ju Hwan Cho, Shin‐Young Park, et al.. (2008). A novel role of hippocalcin in bFGF‐induced neurite outgrowth of H19‐7 cells. Journal of Neuroscience Research. 86(7). 1557–1565. 15 indexed citations
19.
Oh, Doo‐Yi, et al.. (2006). Phospholipase D1 activation through Src and Ras is involved in basic fibroblast growth factor‐induced neurite outgrowth of H19‐7 cells. Journal of Cellular Biochemistry. 101(1). 221–234. 18 indexed citations
20.
Cho, Ju Hwan, et al.. (1997). Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer. Journal of Korean Medical Science. 12(4). 305–305. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026